181 related articles for article (PubMed ID: 37007016)
1. Bicyclol attenuates high fat diet-induced non-alcoholic fatty liver disease/non-alcoholic steatohepatitis through modulating multiple pathways in mice.
Wu J; Jia S; Xu B; Yao X; Shao J; Yao J; Cen D; Yao X
Front Pharmacol; 2023; 14():1157200. PubMed ID: 37007016
[No Abstract] [Full Text] [Related]
2. Bicyclol alleviates high-fat diet-induced hepatic ER stress- and autophagy-associated non-alcoholic fatty liver disease/non-alcoholic steatohepatitis in mice.
Jia S; Jin L; Cheng X; Wu J; Yao X; Shao J; Zhang C; Cen D; Cheng B; Wang J; Chen L; Yao X
Drug Dev Ind Pharm; 2022 Jun; 48(6):247-254. PubMed ID: 35875932
[TBL] [Abstract][Full Text] [Related]
3. Berberine Prevents Disease Progression of Nonalcoholic Steatohepatitis through Modulating Multiple Pathways.
Wang Y; Tai YL; Zhao D; Zhang Y; Yan J; Kakiyama G; Wang X; Gurley EC; Liu J; Liu J; Liu J; Lai G; Hylemon PB; Pandak WM; Chen W; Zhou H
Cells; 2021 Jan; 10(2):. PubMed ID: 33494295
[TBL] [Abstract][Full Text] [Related]
4. Bicyclol attenuates tetracycline-induced fatty liver associated with inhibition of hepatic ER stress and apoptosis in mice.
Yao XM; Li Y; Li HW; Cheng XY; Lin AB; Qu JG
Can J Physiol Pharmacol; 2016 Jan; 94(1):1-8. PubMed ID: 26640164
[TBL] [Abstract][Full Text] [Related]
5. Erratum: Bicyclol attenuates high fat diet-induced non-alcoholic fatty liver disease/non-alcoholic steatohepatitis through modulating multiple pathways in mice.
Frontiers Production Office
Front Pharmacol; 2023; 14():1204546. PubMed ID: 37153786
[TBL] [Abstract][Full Text] [Related]
6. Macrophage-derived thrombospondin 1 promotes obesity-associated non-alcoholic fatty liver disease.
Gwag T; Reddy Mooli RG; Li D; Lee S; Lee EY; Wang S
JHEP Rep; 2021 Feb; 3(1):100193. PubMed ID: 33294831
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of bicyclol on tetracycline-induced fatty liver in mice.
Yu HY; Wang BL; Zhao J; Yao XM; Gu Y; Li Y
Toxicology; 2009 Jul; 261(3):112-8. PubMed ID: 19427351
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial gene polymorphisms alter hepatic cellular energy metabolism and aggravate diet-induced non-alcoholic steatohepatitis.
Schröder T; Kucharczyk D; Bär F; Pagel R; Derer S; Jendrek ST; Sünderhauf A; Brethack AK; Hirose M; Möller S; Künstner A; Bischof J; Weyers I; Heeren J; Koczan D; Schmid SM; Divanovic S; Giles DA; Adamski J; Fellermann K; Lehnert H; Köhl J; Ibrahim S; Sina C
Mol Metab; 2016 Apr; 5(4):283-295. PubMed ID: 27069868
[TBL] [Abstract][Full Text] [Related]
9. Metabolic signatures across the full spectrum of non-alcoholic fatty liver disease.
McGlinchey AJ; Govaere O; Geng D; Ratziu V; Allison M; Bousier J; Petta S; de Oliviera C; Bugianesi E; Schattenberg JM; Daly AK; Hyötyläinen T; Anstee QM; Orešič M
JHEP Rep; 2022 May; 4(5):100477. PubMed ID: 35434590
[TBL] [Abstract][Full Text] [Related]
10. Bicyclol ameliorates nonalcoholic fatty liver disease in mice via inhibiting MAPKs and NF-κB signaling pathways.
Zhao W; Yan Y; Xiao Z; Wang M; Xu M; Wang Z; Wang Y; Zhuang Z; Yang D; Chen G; Liang G
Biomed Pharmacother; 2021 Sep; 141():111874. PubMed ID: 34229251
[TBL] [Abstract][Full Text] [Related]
11. Diallyl disulfide attenuates non‑alcoholic steatohepatitis by suppressing key regulators of lipid metabolism, lipid peroxidation and inflammation in mice.
Zhang N; Wang Y; Zhang J; Liu B; Li G; Xin S; Xu K
Mol Med Rep; 2019 Aug; 20(2):1363-1372. PubMed ID: 31173200
[TBL] [Abstract][Full Text] [Related]
12. A Comparison of the Gene Expression Profiles of Non-Alcoholic Fatty Liver Disease between Animal Models of a High-Fat Diet and Methionine-Choline-Deficient Diet.
Alshawsh MA; Alsalahi A; Alshehade SA; Saghir SAM; Ahmeda AF; Al Zarzour RH; Mahmoud AM
Molecules; 2022 Jan; 27(3):. PubMed ID: 35164140
[TBL] [Abstract][Full Text] [Related]
13. Combined Use of Bicyclol and Berberine Alleviates Mouse Nonalcoholic Fatty Liver Disease.
Li H; Liu NN; Li JR; Dong B; Wang MX; Tan JL; Wang XK; Jiang J; Lei L; Li HY; Sun H; Jiang JD; Peng ZG
Front Pharmacol; 2022; 13():843872. PubMed ID: 35250593
[TBL] [Abstract][Full Text] [Related]
14. Phoenixin 14 Inhibits High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Experimental Mice.
Yang F; Huang P; Shi L; Liu F; Tang A; Xu S
Drug Des Devel Ther; 2020; 14():3865-3874. PubMed ID: 33061293
[TBL] [Abstract][Full Text] [Related]
15. Bicyclol Regulates Hepatic Gluconeogenesis in Rats with Type 2 Diabetes and Non-alcoholic Fatty Liver Disease by Inhibiting Inflammation.
Li H; Xu Q; Xu C; Hu Y; Yu X; Zhao K; Li M; Li M; Xu J; Kuang H
Front Pharmacol; 2021; 12():644129. PubMed ID: 34093184
[TBL] [Abstract][Full Text] [Related]
16. Targeting DUSP7 signaling alleviates hepatic steatosis, inflammation and oxidative stress in high fat diet (HFD)-fed mice via suppression of TAK1.
Wu L; Liu Y; Zhao Y; Li M; Guo L
Free Radic Biol Med; 2020 Jun; 153():140-158. PubMed ID: 32311490
[TBL] [Abstract][Full Text] [Related]
17. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.
Ganz M; Bukong TN; Csak T; Saha B; Park JK; Ambade A; Kodys K; Szabo G
J Transl Med; 2015 Jun; 13():193. PubMed ID: 26077675
[TBL] [Abstract][Full Text] [Related]
18. Bile acids contribute to the development of non-alcoholic steatohepatitis in mice.
Gillard J; Clerbaux LA; Nachit M; Sempoux C; Staels B; Bindels LB; Tailleux A; Leclercq IA
JHEP Rep; 2022 Jan; 4(1):100387. PubMed ID: 34825156
[TBL] [Abstract][Full Text] [Related]
19. Corn Oligopeptide Alleviates Nonalcoholic Fatty Liver Disease by Regulating the Sirtuin Signaling Pathway.
Xu Y; Su T; Mishra H; Ando R; Furutani Y; Lu J; Cai M; Suzuki H; Yu W; Qin XY
J Agric Food Chem; 2024 Mar; 72(12):6360-6371. PubMed ID: 38489847
[TBL] [Abstract][Full Text] [Related]
20. Gasdermin D plays a key role as a pyroptosis executor of non-alcoholic steatohepatitis in humans and mice.
Xu B; Jiang M; Chu Y; Wang W; Chen D; Li X; Zhang Z; Zhang D; Fan D; Nie Y; Shao F; Wu K; Liang J
J Hepatol; 2018 Apr; 68(4):773-782. PubMed ID: 29273476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
